DYAD is a London-based healthcare AI company developing technology to improve the way clinical information is understood and transferred across healthcare. Its proprietary AI system, GENIE, turns unstructured clinical information into structured, usable healthcare data. In primary care, GENIE powers BetterLetter, an AI-powered clinical coding platform that has processed more than five million documents to date. DYAD's technology is already used by more than 200 GP surgeries, with the company supporting the processing of approximately 500,000 clinical letters each month.
DYAD: Venture Capital Funding History
DYAD
DYAD
- Health
- London, United Kingdom
- £7.5m
- dyad.ai
- Update Information
More venture news
- 29 Sept 2026

DYADDYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
Series AHealth - 24 Sept 2026

IMS SolutionsIMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
SeedHealth - 21 Sept 2026

InTouchNowInTouchNow raises a £2.3m seed round led by Ada Ventures to handle inbound patient calls for NHS GP practices
SeedHealth
